Psilocybin at a Regulatory Crossroads: Five Unresolved Questions Shaping the Future of Psychedelic Medicine
Denis Katz, MD Founder & Medical Director, Salience Clinical LLC
Introduction
The optimism surrounding psilocybin is not unfounded. Early clinical findings have been striking enough to attract serious scientific attention, substantial investment, and a level of public interest that...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
